Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
FDA official discusses potential link between COVID-19 vaccines and pediatric deaths - 2Best Veggie lover Dinner: What's Your Plant-Based Pick?
- 3Flu cases spiking this holiday season, CDC data shows
- 4Japanese H3 rocket fails during launch of navigation satellite (video)
- 54 astronauts are now on their path to the moon. Here’s what happens next
- Twelve injured near Beit Shemesh, reports of shrapnel impact in Eilat as Iran targets Israel
- Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)
- Eurasian cargo hub expands to capture Europe-Asia freight flows
- Millions in JDM Exports and Exotic Supercars Are Currently Trapped at Sea
- Tehran synagogue damaged by missile strike according to Iranian media
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
- Israeli archaeologists launch project to trace origins of ancient pottery
- German mid-sized firms gloomy on outlook, survey finds
